Parameter
| Biomarker | LDH | Full name | Lactate dehydrogenase | Molecular Type | Protein （Enzymes） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis、Prediction of treatment response |
| Disease | Renal Cell Carcinoma(RCC) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Serum（Biochemical testing） | ||
| Pathobiological Mechanisms | Participates in anaerobic glycolysis, regulated by the PI3-K/AKT/mTOR pathway, with high expression reflecting tumor burden | ||||
| Clinical Availability Status | Clinically available / Guideline included: core measures of the MSKCC risk score | ||||
| Notes and Dynamics | High LDH indicates poor prognosis and predicts therapeutic benefit with tesilomide | ||||